next generation glp-1 Revolutionizing obesity treatment: The emerging role of receptor agonists and next-generation pharmacotherapies GLP-1 therapies evolving to multi-hormone

Interestingly, acute administration of Ex-4 reduces septal expression of the retrograde messenger 2-arachidonylglycerol (2-AG), as well as a product of its presynaptic degradation, arachidonic acid (AA)

[DOI] [PubMed] [Google Scholar] 154.Serviddio G., Bellanti F., Sastre J., Vendemiale G., Altomare E

Minamino, D

Your friend, CG- Texas Functional Cranial-Release is the art and science of restoring normal brain and nervous system function by using Functional Neurology along with Specific Endo-nasal balloon manipulation to do the following: 1) Restore the brains ability to oxygenate itself through both improving air flow into higher areas through the nasal passage and also improve the normal pumping action inherent in all of use (cranial rhythm) that moves nutrients such as oxygen and neurotransmitters that bath the central nervous system keeping it healthy

1 The GLP-1 hormone controls key metabolic processes: it triggers the release of insulin to reduce blood sugar levels after spikes, helps slow down digestion for optimal nutrient absorption and signals the brain when to stop eating